
This episode features Olivier Godement, Head of Product for Business Products at OpenAI, discussing the current state and future of AI adoption in enterprises, with a particular focus on the recent releases of GPT 5.1 and Codex. The conversation explores how these models are achieving meaningful automation in specific domains like coding, customer support, and life sciences: where companies like Amgen are using AI to accelerate drug development timelines from months to weeks through automated regulatory documentation. Olivier reveals that while complete job automation remains challenging and requires substantial scaffolding, harnesses, and evaluation frameworks, certain use cases like coding are reaching a tipping point where engineers would "riot" if AI tools were taken away. The discussion covers the importance of cost reduction in unlocking new use cases, the emerging significance of reinforcement fine-tuning (RFT) for frontier customers, and OpenAI's philosophy of providing not...
Subscribe to your favorite podcasts and get free AI summaries within minutes of release.
Browse trending podcasts or search for your favorites
One click to follow any show — always free, no credit card
Free AI summaries delivered by email within minutes of release
Free forever · No credit card · Unsubscribe anytime
Never miss an episode of Unsupervised Learning with Jacob Effron. Subscribe for free →
No transcript available.